Results 151 to 160 of about 20,955 (188)

Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction. [PDF]

open access: yesNat Commun
Clemente-Moragón A   +13 more
europepmc   +1 more source

Intravenous acellular human amniotic fluid prevents ischemic cardiac remodeling. [PDF]

open access: yesSci Rep
Mitchell G   +12 more
europepmc   +1 more source

Individual and combined effects of ischemic conditioning strategies on infarct size after myocardial ischemia reperfusion. [PDF]

open access: yesSci Rep
Elmahdy A   +11 more
europepmc   +1 more source

Obesity and Cardioprotection

Current Medicinal Chemistry, 2020
The incidence of obesity and diabetes is increasing rapidly worldwide. Obesity and metabolic syndrome are strictly linked and represent the basis of different cardiovascular risk factors, including hypertension and inflammatory processes predisposing to ischemic heart disease, which represent the most common causes of heart failure.
Femminò, Saveria   +2 more
openaire   +2 more sources

Cardioprotection

Der Anaesthesist, 2012
The demographic change is associated with an increasing number of elderly patients with serious comorbidities. The prevalence of coronary heart disease in particular increases with age and raises the risk of perioperative myocardial ischemia. In the last few years various interventions have been evaluated to lower the perioperative risk for serious ...
David J. Lefer, Roberto Bolli
openaire   +3 more sources

Opioids and cardioprotection

Pharmacology & Therapeutics, 2001
Opioid peptides and exogenous opioids such as morphine are known to exert important cardiovascular effects. However, until recently, it was not appreciated that activation of specific receptors results in a potent cardioprotective effect to reduce infarct size in experimental animals and to reduce cell death in isolated cardiomyocytes.
J E, Schultz, G J, Gross
openaire   +2 more sources

Home - About - Disclaimer - Privacy